Maximizing Efficacy of Antidepressants: Beyond Selective Serotonin Reuptake Inhibitors
Review the neurotransmitters involved in depression and antidepressant treatment response.
Pain and the Brain: Chronic Widespread Pain
In this interactive case, determine the best treatment strategy for Ms. A and learn psychotherapeutic approaches to help relieve her chronic pain.
A Randomized, Double-Blind Study of Increasing or Maintaining
Duloxetine Dose in Patients Without Remission of Major
Depressive Disorder After Initial Duloxetine Therapy. Susan
G. Kornstein, M.D.; David L. Dunner, M.D.; Adam L. Meyers, M.S.;
Virgil G. Whitmyer, Ph.D.; Craig H. Mallinckrodt, Ph.D.;
Madelaine M. Wohlreich, M.D.; Michael J. Detke, M.D.; Millie S.
Hollandbeck, B.S.; and John H. Greist, M.D.
[Abstract]
[PDF]
Posted 7/15/08
Monthly Administration of Long-Acting Injectable Risperidone
and Striatal Dopamine D2 Receptor Occupancy for the
Management of Schizophrenia. Hiroyuki Uchida, M.D., Ph.D.;
David C. Mamo, M.D., M.Sc., F.R.C.P.C.; Shitij Kapur, M.D.,
Ph.D., F.R.C.P.C.; Alain Labelle, M.D., F.R.C.P.C.; Chekkera
Shammi, M.B.B.S., F.R.C.P.C.; Erik J. L. Mannaert, Ph.D.; Steve
W. Mann, B.A.; and Gary Remington, M.D., Ph.D., F.R.C.P.C.
[Abstract] [PDF]
Posted 7/15/08
Antidepressant-Associated Mood Elevations in Bipolar II
Disorder Compared With Bipolar I Disorder and Major Depressive
Disorder: A Systematic Review and Meta-Analysis. David J.
Bond, M.D., F.R.C.P.C.; Melissa M. Noronha, R.P.N.;Marcia
Kauer-Sant'Anna, M.D., Ph.D.; Raymond W. Lam, M.D., F.R.C.P.C.;
and Lakshmi N. Yatham, M.B.B.S., F.R.C.P.C., M.R.C.Psych. (U.K.)
[Abstract] [PDF]
Posted 7/15/08
An 8-Week, Open-Label Trial of Duloxetine for Comorbid Major
Depressive Disorder and Chronic Headache. Fernando M. Volpe,
M.D., Ph.D.
[Abstract] [PDF]
Posted 7/15/08
Multiple Genetic Factors in Olanzapine-Induced Weight Gain in
Schizophrenia Patients: A Cohort Study. Hiroshi Ujike, M.D.,
Ph.D.; Akira Nomura, M.D., Ph.D.; Yukitaka Morita, M.D., Ph.D.;
Akiko Morio, M.D.; Yuko Okahisa, M.D.; Tatsuya Kotaka, M.D.;
Masafumi Kodama, M.D., Ph.D.; Takeshi Ishihara, M.D., Ph.D.; and
Shigetoshi Kuroda, M.D., Ph.D.
[Abstract] [PDF]
Posted 7/15/08
Implementation of a Schizophrenia Practice Guideline:
Clinical Results. Stefan Weinmann, M.D., Dr.P.H.; Susanne
Hoerger; Monika Erath; Reinhold Kilian, Dr.P.H.; Wolfgang Gaebel,
M.D.; and Thomas Becker, M.D.
[Abstract] [PDF]
Posted 7/15/08
Efficacy of Bupropion and the Selective Serotonin Reuptake
Inhibitors in the Treatment of Major Depressive Disorder With
High Levels of Anxiety (Anxious Depression): A Pooled Analysis
of 10 Studies. George I. Papakostas, M.D.; Stephen M. Stahl,
M.D.; Alok Krishen, M.Sc. (Hons. Sch.), M.S.; Cheryl A. Seifert,
B.A.;Vivian L. Tucker, Pharm.D.; Elizabeth P. Goodale, Pharm.D.;
and Maurizio Fava, M.D.
[Abstract]
[PDF]
Posted 7/1/08
Tardive Dyskinesia and the 3-Year Course of Schizophrenia:
Results From a Large, Prospective, Naturalistic Study. Haya Ascher-Svanum, Ph.D.; Baojin Zhu, Ph.D.; Douglas Faries, Ph.D.; Xiaomei
Peng, M.D.; Bruce J. Kinon, M.D.; and Mauricio Tohen, M.D.
[Abstract] [PDF]
Posted 6/24/08
Generalizability of Clinical Trial Results for Major
Depression to Community Samples. Carlos Blanco, M.D., Ph.D.;
Mark Olfson, M.D., M.P.H.; Renee D. Goodwin, Ph.D., M.P.H.;
Elizabeth Ogburn, M.S.; Michael R. Liebowitz, M.D.; Edward V.
Nunes, M.D.; and Deborah S. Hasin, M.D.
[Abstract] [PDF]
Posted 6/10/08
Vitamins B12, B6, and Folic Acid for
Onset of Depressive Symptoms in Older Men: Results From a 2-Year
Placebo-Controlled Randomized Trial. Andrew H. Ford, M.B.B.S.;
Leon Flicker, M.B.B.S., Ph.D., F.R.A.C.P.; Jenny Thomas, R.N.;
Paul Norman, M.B.B.S., Ph.D., F.R.A.C.S.; Konrad Jamrozik,
M.B.B.S., D.Phil.; and Osvaldo P. Almeida, M.D., Ph.D.,
F.R.A.N.Z.C.P.
[Abstract] [PDF]
Posted 6/10/08
Language in Alzheimer's Disease. Myron F. Weiner, M.D.;
Katherine E. Neubecker, B.A.; Mary E. Bret, M.D.; and Linda S.
Hynan, Ph.D.
[Abstract] [PDF]
Posted 5/20/08
Missed Diagnosis of Psychotic Depression at 4 Academic
Medical Centers. Anthony J. Rothschild, M.D.; Jesse Winer,
M.D.; Alastair J. Flint, M.B., F.R.C.P.C., F.R.A.N.Z.C.P.;
Benoit H. Mulsant, M.D.; Ellen M. Whyte, M.D.; Moonseong Heo,
Ph.D.; Susan Fratoni, B.A.; Michelle Gabriele, M.S.W.; Sonja
Kasapinovic, M.Sc.; and Barnett S. Meyers, M.D.; for the Study
of Pharmacotherapy of Psychotic Depression (STOP-PD)
Collaborative Study Group
[Abstract] [PDF] Posted
4/1/08
Racial and Ethnic Effects on Psychotic Psychiatric Diagnostic
Changes From Admission to Discharge: A Retrospective Chart
Review. Deidre M. Anglin, Ph.D., and Dolores Malaspina, M.D.
[Abstract] [PDF]
Posted 2/27/08
Escitalopram in the Treatment of Impulsive-Compulsive
Internet Usage Disorder: An Open-Label Trial Followed by a
Double-Blind Discontinuation Phase. Bernardo Dell'Osso, M.D.;
SallieJo Hadley, M.D.; Andrea Allen, Ph.D.; Bryann Baker, B.A.;
William F. Chaplin, Ph.D.; and Eric Hollander, M.D.
[Abstract] [PDF] Posted
2/27/08
Original Articles
1033 Prevalence, Correlates, Disability, and Comorbidity
of DSM-IV Narcissistic Personality Disorder:
Results From the Wave 2 National Epidemiologic
Survey on Alcohol and Related Conditions. Frederick S. Stinson, Deborah A. Dawson,
Risë B. Goldstein, S. Patricia Chou, Boji Huang,
Sharon M. Smith, W. June Ruan, Attila J. Pulay,
Tulshi D. Saha, Roger P. Pickering,
and Bridget F. Grant
[Abstract]
[PDF]
1046 A Multicenter, Randomized, Double-Blind Study of
the Effects of Aripiprazole in Overweight Subjects
With Schizophrenia or Schizoaffective Disorder
Switched From Olanzapine.
John W. Newcomer, Joao Alberto Campos,
Ronald N. Marcus, Christopher Breder,
Robert M. Berman, Wendy Kerselaers,
Gilbert J. L'Italien, Marleen Nys,
William H. Carson, and Robert D. McQuade
[Abstract]
[PDF]
1057 Clinical Correlates of Patients With Rapid-Cycling Bipolar Disorder and a Recent History of Substance Use Disorder: A Subtype Comparison From Baseline Data of 2 Randomized, Placebo-Controlled Trials. Keming Gao, Marcia L. Verduin, David E. Kemp, Bryan K. Tolliver, Stephen J. Ganocy, Omar Elhaj, Sarah Bilali, Kathleen T. Brady, Robert L. Findling, and Joseph R. Calabrese
[Abstract]
[PDF]
1064 National Patterns in Antidepressant Treatment by Psychiatrists and General Medical Providers: Results From the National Comorbidity Survey Replication. Ramin Mojtabai and Mark Olfson
[Abstract]
[PDF]
1075 Onset of Depressive Episodes Is Faster in Patients With Bipolar Versus Unipolar Depressive Disorder: Evidence From a Retrospective Comparative Study. Ulrich Hegerl, Anja-Christine Bottner, Bettina Holtschmidt-Täschner, Christoph Born, Florian Seemüller, Winfried Scheunemann, Michael Schütze, Heinz Grunze, Verena Henkel, Roland Mergl, and Jules Angst
[Abstract]
[PDF]
1081 Reach of Benchmark Psychiatric Trial Results to Community-Based Providers: A Case Study of CATIE. Timothy J. Petersen, Jeff C. Huffman, Anthony P. Weiss, Mark A. Blais, Charissa F. Andreotti, Madeline B. Horwitz, and Robert J. Birnbaum
[Abstract]
[PDF]
1087 Reduced Posterior Hippocampal Volume
in Posttraumatic Stress Disorder. Omer Bonne, Meena Vythilingam, Masatoshi Inagaki, Suzanne Wood, Alexander Neumeister, Allison C. Nugent, Joseph Snow, David A. Luckenbaugh, Earle E. Bain, Wayne C. Drevets, and Dennis S. Charney
[Abstract]
[PDF]
1092 A Preliminary Study of fMRI-Guided rTMS
in the Treatment of Generalized Anxiety Disorder. Alexander Bystritsky, Jonas T. Kaplan, Jamie D. Feusner, Lauren E. Kerwin, Mitali Wadekar, Mark Burock, Allan D. Wu, and Marco Iacoboni
[Abstract]
[PDF]
1099 Minor Increase in Risk of Road Traffic Accidents After Prescriptions of Antidepressants: A Study of Population Registry Data in Norway. Jørgen G. Bramness, Svetlana Skurtveit, C. Ineke Neutel, Jørg Mørland, and Anders Engeland
[Abstract]
[PDF]
1104 Association Study of the Decreased Serum BDNF Concentrations in Amnestic Mild Cognitive Impairment and the Val66Met Polymorphism in Chinese Han. Hui Yu, Zhijun Zhang, Yongmei Shi, Feng Bai, Chunming Xie, Yun Qian, Yonggui Yuan, and Linglong Deng
[Abstract]
[PDF]
1112 Racial/Ethnic Disparities in Service Utilization for Individuals With Co-Occurring Mental Health and Substance Use Disorders in the General Population: Results From the National Epidemiologic Survey
on Alcohol and Related Conditions. Mark L. Hatzenbuehler, Katherine M. Keyes,
William E. Narrow, Bridget F. Grant,
and Deborah S. Hasin
[Abstract]
[PDF]
1122 The Frequency of Cognitive Impairment in Patients With Anxiety, Depression, and Bipolar Disorder: An Unaccounted Source of Variance
in Clinical Trials. C. Thomas Gualtieri and Dexter W. Morgan
[Abstract]
[PDF]
1131 A Randomized, Controlled Trial of Group Cognitive-Behavioral Therapy for Compulsive Buying Disorder: Posttreatment and 6-Month Follow-Up Results. Astrid Mueller, Ulrike Mueller, Andrea Silbermann,
Hans Reinecker, Stefan Bleich, James E. Mitchell,
and Martina de Zwaan
[Abstract]
[PDF]
1139 Exploring the Correlates of Suicide Attempts Among Individuals With Major Depressive Disorder: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions. James M. Bolton, Shay-Lee Belik, Murray W. Enns,
Brian J. Cox, and Jitender Sareen
[Abstract]
[PDF]
Focus on Childhood and Adolescent Mental Health
1150 Effects of Stimulant Medication on Neuropsychological Functioning in Young Adults With Attention-Deficit/Hyperactivity Disorder. Joseph Biederman, Larry J. Seidman, Carter R. Petty, Ronna Fried, Alysa E. Doyle, Daniel R. Cohen,
Deborah C. Kenealy, and Stephen V. Faraone
[Abstract]
[PDF]
1157 Neuroleptic Malignant Syndrome Associated
With Atypical Antipsychotics in Pediatric Patients: A Review of Published Cases. Paul E. Croarkin, Graham J. Emslie, and Taryn L. Mayes
[Abstract]
[PDF]
1166 Metabolic and Hormonal Side Effects
in Children and Adolescents Treated With
Second-Generation Antipsychotics. David Fraguas, Jessica Merchán-Naranjo,
Paula Laita, Mara Parellada, Dolores Moreno,
Ana Ruiz-Sancho, Alicia Cifuentes,
Marisa Giráldez, and Celso Arango
[Abstract]
[PDF]
Academic Highlights
1176 A Roadmap to Key Pharmacologic Principles
in Using Antipsychotics in the Treatment of
Bipolar Disorder. [CME]
[PDF]
ASCP Corner
1184 Sequenced Treatment Alternatives to Relieve Depression (STAR*D): Lessons Learned. Sidney Zisook, Krauz Ganadjian, Christine Moutier, Richard Prather, and Sanjai Rao
[PDF]
Letters To the Editor [PDF]
1186 Treatment-Resistant Self-Mutilation, Tics,
and Obsessive-Compulsive Disorder in Neuroacanthocytosis: A Mouth Guard
as a Therapeutic Approach. Leonardo F. Fontenelle
and Marco Antônio Araújo Leite
1187 The Continuum Hypothesis of Mood Disorders.
Franco Benazzi
1189 Atomoxetine-Associated Hemospermia:
A Case Report. Y. Pritham Raj
1189 Parkinsonism and Akathisia With Quetiapine:
Three Case Reports. Rahul Bharadwaj and Sandeep Grover
1191 Transcranial Magnetic Stimulation:
Clinical Applications Beyond Depression. Shailendra Kapoor
Book Reviews 1193 [PDF]
Electronic CME Activities
Available through www.psychiatrist.com/toc
e19 Diagnosing Depressive Mixed States
in Bipolar Disorders. Steven C. Dilsaver and Franco Benazzi
[Abstract]
e20 Sedation as a Side Effect of the Treatment
of Mental Disorders. John M. Kane
[Abstract]
e21 Incorporating Trial Data Into
Bipolar Disorder Management. Terence A. Ketter
[Abstract]
Past TOCs | SuppleNet | Buy a Single Article
The Journal of Clinical Psychiatry is the official journal of the American Society for Clinical Psychopharmacology
| Online Journal Offerings (choose a year) | ||||||||||
| 2000s | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | |
| 1990s | 1996 | 1997 | 1998 | 1999 | ||||||
Special Sections
Focus on Childhood and Adolescent Mental Health
Academic Highlights Feature
Clinical Insights Into Pharmacogenetics and Schizophrenia, Part 1
Genetic information may predict which patients will respond best to certain pharmacotherapies, which could revolutionize the way clinicians practice medicine. Read this Academic Highlights to find out about the practicality of pharmacogenetic testing and learn how pharmacogenetics can be used to assess response and improve adherence for your patients with schizophrenia.
Electronic Activities
Diagnostic Dilemmas and Clinical Correlates of Mixed States in Bipolar Disorder
Treating Movement Disorders and Akathisia as Side Effects of Antipsychotic Pharmacotherapy
The Role of Psychosocial Interventions in Bipolar II Disorder: What Do We Know?
SuppleNet Feature
The Use of Atypical Antipsychotics in Pediatric Psychiatric Disorders
Psychiatric disorders in childhood and adolescence are increasingly prevalent and associated with a poor prognosis without early intervention. This new Supplement examines how early onset impacts the course of illness and reviews the use of atypical antipsychotics and psychosocial interventions to optimize outcomes for young patients.
JCP CME
Understanding Fibromyalgia and Its Related Disorders
Read this Supplement to learn about the signs and symptoms of fibromyalgia and discover efficacious treatments to manage your patients with this condition as well as its comorbidities.
Multimedia CME
Effective Agents in Treating Bipolar Depression
NEW! In this online interactive report, you can learn how to optimize the acute and maintenance therapy of your patients with bipolar depression by using the most effective agents.
CME Partners
Practical Strategies for Diagnosing and Treating Depression in Women: Chronic Depression
Participate in this interactive case to determine the best diagnosis and treatment for Ms. A, a 55-year-old woman who presents with fatigue, low self-esteem, and anhedonia.
Institutional Members
New Developments in the Treatment of Attention-Deficit/Hyperactivity Disorder
With this Supplement, you can review the neurobiology of ADHD and find out how to manage this disorder, including its common comorbidities.
INFORMATION FOR AUTHORS
If your manuscript fits within the scope of the journal, we encourage you to submit. Acceptance is contingent on favorable peer review.
Our user-friendly electronic manuscript submission and peer review system allows you to submit your manuscript online securely, conveniently, and instantly. Authors can track the progress of their manuscripts from submission to publication. Assistance is available via e-mail if needed.
First-time submitters will need to register for an account. After you follow the link above for the submission page, select “New authors should register for an account.” Note that this account is separate from your Net Society account, so even if you are a member of the Net Society (which provides search privileges for our Web site and the ability to obtain free CME credit), you will still need to establish an account to use the manuscript submission system.
Acceptance rate |
31% |
|
No. of articles published per issue |
Mean=16, range=14–22 |
|
Submission-to–first decision time (mean) |
40.9 days |
|
Submission-to–final decision time (mean) |
51.6 days |
|
Submission-to-acceptance time (estimated average) |
4 months |
|
Acceptance-to-publication time |
Mean=5.2 months, |
The Journal of Clinical Psychiatry continues to be ranked as the most-read and 6th most-cited psychiatric journal in the world (according to the Focus Readership Study, June 2007, and Citation Index, July 2007, respectively). The Journal mails to about 35,184 recipients,* and over 20,000 allied mental health professionals have requested daily receipt of informational e-mails about our journals and Web CME activities.
The JCP is also a member of BPA Worldwide and is the official journal of the American Society of Clinical Psychopharmacology, which consists of 800 members who are biopsychiatric researchers, academicians, and clinicians.
*Source: BPA Circulation Statement, June 2007
See the form in PDF format. At the time of article submission, each author must submit a form incorporating 4 statements: (1) authorship, (2) copyright transfer or federal employment, and (3) financial or other relationships that might pose a conflict of interest. The corresponding author must sign (4) the Acknowledgment statement. This form can be mailed to Physicians Postgraduate Press, P.O. Box 752870, Memphis, TN 38175-2870, faxed to the Production Coordinator at 901-273-2752, or scanned and uploaded during the electronic submission process.
See the checklist.
See the guidelines.
Authors receive a complimentary copy of the issue in which their article or letter appears and are sent a reprint order form at the time their article is published.
Authors can also order single copies of articles or back issues, as well as larger quantities of high-quality photocopies or reprints. Learn more about reprints.
See the clinical trials registration information in our Information for Authors.
Material published in the Journal is embargoed until the 15th of the month of issue. Contact .
INFORMATION FOR REVIEWERS
Manuscripts that meet the Journal’s scope and submission criteria are sent to expert consultants for peer review.
Reviewers who have a financial or personal conflict of interest related to a manuscript are obligated to decline the reviewer position.
The peer review process is conducted using the electronic submission system used for manuscripts. Potential reviewers are queried in advance about their availability. While reviewers are asked to complete their reviews within 3 weeks of receiving the manuscript, more expeditious turnaround is highly valued. If you would like to be a peer reviewer, please send your CV to .
The reviewers' identities are not revealed, and strict confidentiality regarding the submitted manuscript is maintained. Reviewers must not keep copies of the manuscripts they review or discuss any of the information or data with others.
Peer review is essential to a medical journal, and each year, those peer reviewers who have carried the heaviest load and reviewed the greatest number of manuscripts are recognized as members of the Journal’s Circle of Honor.
The Circle of Honor is the Journal’s acknowledgment of the indispensable contribution—the dedication, scholarship, and scientific rigor—generously donated by these individuals.
2006 Circle of Honor
James Dalen, M.D., M.P.H.
James H. Kocsis, M.D.
David C. Emelity, M.D.
Francisco A. Moreno, M.D.
Maurizio Fava, M.D.
Michael K. Popkin, M.D.
Marlene P. Freeman, M.D.
George M. Simpson, M.D.
Scott A. Freeman, M.D.
Michael E. Thase, M.D.
Anne Herring, R.N., Ph.D.
Mauricio F. Tohen, M.D., Dr.P.H.
David B. Herzog, M.D.
James W. Jefferson, M.D.
Carlos A. Zarate, Jr., M.D.
John M. Kane, M.D.
Mark Zimmerman, M.D.
Samuel J. Keith, M.D.
Psychiatrist.com Home
Keyword Search